GeoVax Labs, Inc.(GOVX)
Pharmaceuticals
Vaccine Manufacturers
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-10-20 | SPENCER JOHN N JR Director | Purchase | +10,000 | +87.70%21,402 | $0.55 | $5,498 | View SEC filing | |
| 2025-08-08 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +1,107 | +46.38%3,494 | $0.67 | $742 | View SEC filing | |
| 2025-04-11 | SPENCER JOHN N JR Director | Purchase | +10,000 | +713.27%11,402 | $0.98 | $9,800 | View SEC filing | |
| 2025-04-10 | Sharkey John W. VP, Business Development | Purchase | +6,000 | +3141.36%6,191 | $0.99 | $5,940 | View SEC filing | |
| 2025-04-01 | DODD DAVID A President, CEO | Purchase | +10,000 | +37.51%36,661 | $1.08 | $10,800 | View SEC filing | |
| 2025-03-31 | Reynolds Mark CFO | Purchase | +6,800 | +94.27%14,013 | $1.08 | $7,343 | View SEC filing | |
| 2024-08-12 | DODD DAVID A President, CEO | Purchase | +8,000 | +42.87%26,661 | $1.95 | $15,600 | View SEC filing | |
| 2024-02-22 | DODD DAVID A President, CEO | Purchase | +8,729 | +87.89%18,661 | $2.27 | $19,781 | View SEC filing | |
| 2024-02-07 | Reynolds Mark CFO | Purchase | +2,000 | +38.37%7,213 | $2.77 | $5,540 | View SEC filing | |
| 2023-12-26 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +6,944 | +24.08%35,782 | $0.36 | $2,500 | View SEC filing | |
| 2023-09-27 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +9,653 | +50.32%28,838 | $0.52 | $5,020 | View SEC filing | |
| 2023-08-28 | DODD DAVID A President, CEO | Purchase | +35,087 | +30.81%148,957 | $0.57 | $20,000 | View SEC filing | |
| 2023-08-21 | Reynolds Mark CFO | Purchase | +10,000 | +14.67%78,184 | $0.52 | $5,179 | View SEC filing | |
| 2023-04-25 | DODD DAVID A President, CEO | Purchase | +32,000 | +39.09%113,870 | $0.64 | $20,445 | View SEC filing | |
| 2023-04-21 | Reynolds Mark CFO | Purchase | +8,000 | +13.29%68,184 | $0.63 | $5,040 | View SEC filing | |
| 2022-09-23 | CHASE RANDAL D Director | Purchase | +10,000 | +37.58%36,613 | $1.10 | $11,000 | View SEC filing | |
| 2022-07-05 | Sharkey John W. VP, Business Development | Purchase | +1,000 | +53.76%2,860 | $0.82 | $820 | View SEC filing | |
| 2022-06-28 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +4,464 | +30.32%19,185 | $1.12 | $5,000 | View SEC filing | |
| 2022-06-22 | CHASE RANDAL D Director | Purchase | +10,000 | +60.19%26,613 | $1.21 | $12,100 | View SEC filing | |
| 2022-05-06 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +9,722 | +194.48%14,721 | $0.72 | $7,000 | View SEC filing | |
| 2022-05-05 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +4,999 | +100.00%4,999 | $0.71 | $3,549 | View SEC filing | |
| 2020-09-29 | Reynolds Mark CFO | Purchase | +120,368 | +100.00%120,368 | $2.50 | $300,920 | View SEC filing | |
| 2020-09-29 | DODD DAVID A President, CEO | Purchase | +163,740 | +100.00%163,740 | $2.50 | $409,350 | View SEC filing | |
| 2020-09-29 | MCNALLY ROBERT T Director | Purchase | +107,850 | +100.00%107,850 | $2.50 | $269,625 | View SEC filing | |
| 2020-09-29 | SPENCER JOHN N JR Director | Purchase | +42,048 | +100.00%42,048 | $2.50 | $105,120 | View SEC filing |
1-25 of 80